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inferential anomaly is avoided using OR, with odds of progres-
sion (0.83) the reciprocal of that for no progression (1.21), and
ARD of 4.1% in favor of Nataluzimab with progression or no
progression. For direct comparisons ARD is shown to be consis-
tently estimated with OR but change with framing of effects
using RR wherever epidemiological risk differs from trial risk in
the comparator arm. CONCLUSIONS: Odds ratios allow con-
sistent estimation of absolute risk differences regardless of
framing of effects in direct and indirect comparisons. This over-
comes inferential anomalies that arise with use of relative risk in
such comparisons whenever base risk differs in the jurisdiction of
interest from that in trials, or base risk in the common arms
differs in indirect comparisons. Consequently, odds ratios avoid
selection biases in framing of effects inherent with risk ratios and
are suggested as the preferred metric in estimating such risk
differences.
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OBJECTIVES: The economic literature suggests the Value of
Statistical Life (VSL) as a common measure of efﬁciency for life
saving interventions throughout different societal sectors. Policy
decisions in The Netherlands have not yet been explicitly based
on this measure, however a trade off between wealth and mor-
tality risk is made implicitly when deciding whether or not to
implement a life saving intervention. This study aimed to gain
insights into this trade off, referred to as Implicit Value of
Statistical Life (IVSL), by means of a retrospective investment
analysis of interventions implemented in The Netherlands.
METHODS: A literature search was conducted to ﬁnd life saving
intervention cases meeting the requirements for a uniform IVSL
calculation and additional inclusion criteria. A sample of 10
cases was included in the study and concerned interventions
implemented in the water control, consumer safety, transport and
health care sector. RESULTS: IVSL estimates derived from the
cases ranged from €1 to almost €11 million. Differences were
most extreme when comparing IVSL estimates of interventions
implemented in different societal sectors. However, estimates also
varied greatly between interventions in the same sector and even
within the same intervention, when critical assumptions were
altered. CONCLUSIONS: Despite limited comparability of IVSL
estimates, our ﬁndings suggest that there are great imbalances
between societal investments for preventing a statistical death.
This highlights the need to develop ways to increase transparency
and efﬁciency of policy decisions by systematically taking the
Value of Statistical Life into account. Given the conceptual prob-
lems inherent to the IVSL, future research should focus on the
potential merit of explicit VSL measures for decision making.
Since the consequences of life saving interventions are not
restricted to mortality reduction, research should also address the
question whether there is a need to incorporate broader health
and other consequences of life saving interventions in the
measure of efﬁciency.
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OBJECTIVES: There are two main approaches to questionnaire
translation for languages spoken in multiple countries called
“universal approach” and “country speciﬁc approach”. The uni-
versal approach postulates that one translation can be developed
via participation and consensus between native speaking trans-
lators from various countries where that language is spoken.
Demonstrating that the universal approach is possible for ques-
tionnaires has been the life work of neuropsychologist Dr. Lidia
Artiola Fortuny. METHODS: This poster will share the results of
a study published in the Journal of the International Neuropsy-
chological Society where participants from the US-Mexico
border region (N = 185) and Madrid, Spain (N = 205) were
compared on 16 Spanish language neuropsychological measures,
with special attention to avoid item content that was speciﬁc to
one geographic group. Differences in socio-economic, education
and health were considered. Samples were drawn from volun-
teers in each community between the ages of 18 and 76 with 0 to
20 or more years of formal education who claimed Spanish as
their ﬁrst language and demonstrated native ﬂuency in the lan-
guage. Participants were excluded from the study if they had past
neurological, emotional, psychological issues or learning difﬁcul-
ties. RESULTS: Analyses of variance were performed to study
place of birth effects on performance on each measure. Findings
indicate that the populations from Spain and the Borderland
obtained similar results for most of the measures. Participants
did not report difﬁculties with the instructions or test items.
CONCLUSIONS: Dr. Artiola Fortuny asserts that Spanish
speaking populations do not differ any more than mainstream
English speaking populations such as the United States, England
or Australia, and that one should capitalize on the great amount
of linguistic overlap across populations that share the Spanish
language.
PMC63
SYSTEMATIC REVIEW RELIABILITY: SENSITIVITY AND
SPECIFICITY OF ONEVS.TWO REVIEWS
Muston D,Alnwick K
Heron Evidence Development Ltd, Letchworth, Hertfordshire, UK
OBJECTIVES: In a systematic review of literature, reviewing
abstracts twice by two reviewers improves the likelihood of
correctly including relevant citations and excluding irrelevant
ones. During the second abstract review, the reviewer has had
more exposure to the literature, and thus may be more accurate
than the ﬁrst reviewer. A statistical model was ﬁtted to determine
between-reviewer and between-review reliability and variation.
METHODS: Inclusion/exclusion decisions made by two review-
ers in the abstract review stage of six recently conducted clinical
and economic systematic reviews were analysed in the context of
the ﬁnal inclusion/exclusion decision. For the ﬁrst and second
reviewers, sensitivity (the proportion of correctly included
citations) and speciﬁcity (the proportion of correctly excluded
citations) were modelled using bayesian poisson regression.
RESULTS: Across one economic and ﬁve clinical systematic
reviews, the sensitivity of reviewer one ranged from 82% to
95%; the second reviewer’s sensitivity ranged from 80% to 98%.
The speciﬁcity of reviewer one ranged from 94% to 98%;
the second reviewer’s speciﬁcity ranged from 92% to 99%. The
pattern of results varied substantially between reviews. In
the breast cancer, hyperlipidemia, and anaesthesia reviews, the
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second reviewer was up to 3% more sensitive than the ﬁrst. In the
ovarian cancer, anti-infectives, hyperlipidemia, and clinical
breast cancer reviews, the second reviewer was up to 2% more
speciﬁc than the ﬁrst; all were signiﬁcant differences apart from
the clinical breast cancer review. In the cases where the second
reviewer was less sensitive or speciﬁc than the ﬁrst, these differ-
ences were non-signiﬁcant. CONCLUSIONS: While ﬁrst and
second reviewers tend to have similar sensitivity in including
citations, second reviewers tend to be more accurate at excluding
citations. This may be explained by the fact that, since more
caution is exercised in excluding citations than including them,
reviewers may wait until they have gained sufﬁcient experience to
make this decision.
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OBJECTIVES: To determine 12-months administrative preva-
lence rate of tic disorders (TD) and Tourette syndrome (TS), as
well as their coexistence with ADHD in a large German commu-
nity sample, against the background of the clinical importance of
this association. METHODS: Data for patients with a diagnosis
of any tic disorder (F95, ICD-10), Tourette disorder (F95.2), or
ADHD (F90.0 and/or F90.1) were extracted from the Nord-
baden claims database, covering the complete subpopulation
insured by Statutory Health Insurance (2.238 million lives in
2003; for comparison: total German population insured by SHI
in 2003, 70.2 million) in Nordbaden in South-Western Germany
(representing 82% of the total regional population). RESULTS:
A total of 3,618 patients with a diagnosis of any TD (hereof, 215
with TS) and 11,875 patients with ADHD were identiﬁed, cor-
responding to overall administrative prevalence rates (across all
age groups) of 0.16% (TD), 0.01% (TS), and 0.53% (ADHD).
Males were generally more often afﬂicted with any of the disor-
ders analyzed than females (TD, 0.19% versus 0.13% for
females; TS, 0.02% versus 0.01%; ADHD, 0.83% versus
0.27%). TD and TS were most prevalent among children 7–12
years (0.79% and 0.04%, respectively), and were signiﬁcantly
associated with presence of ADHD. ADHD was reported in
11.2% of children age 12 years with TD (boys, 15.4%; girls,
4.5%), compared to 3.1% (boys, 4.4%; girls, 1.7%) in the
community covered. Among adolescents (age 13–18 years), a
diagnosis of ADHD was tenfold more likely in patients with TD
(15.1%; boys, 18.5%; girls, 7.7%) compared with the commu-
nity group (1.5%; boys, 2.3%; girls, 0.7%). CONCLUSIONS:
These data extend the epidemiological database by providing for
the ﬁrst time information from Germany on the administrative
prevalence of TD, TS, and ADHD, as well as their coexistence,
hereby highlighting the relevance of taking comorbidity into
account when designing health care utilization and burden of
disease studies.
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OBJECTIVES: The majority (50–80%) of patients with general-
ized anxiety disorder (GAD) suffer from a variety of sleep prob-
lems. The objective of this study was to measure the direct effect
of anxiolytic treatment and, separately, its indirect effect medi-
ated by anxiety symptoms on sleep disturbance in patients with
GAD. METHODS: Data were obtained from an 8-week, double-
blind, randomized, ﬂexible-dose, placebo- and active-control
study in 372 GAD patients. Patients were assigned to pre-
gabalin (300–600 mg/day), venlafaxine XR (75–225 mg/day),
or placebo. Anxiety symptoms were measured by clinician-
administered HAM-A scale at baseline and on weeks 1–4, 6, and
8 and sleep disturbances were measured using the 4-item sleep
disturbance subscale on Medical Outcomes Study Sleep Scale
(MOS-SS), a validated patient-reported outcome measure. Statis-
tical mediation modeling was used to estimate the direct effects of
pregabalin and venlafaxine XR (relative to placebo) and the
indirect effects via anxiety symptoms, the mediator variable, as
measured by HAM-A total score. All available data from the trial
were used in the statistical analyses. RESULTS: Patients were
predominantly female (61%) and had a mean age of 41 years.
Path coefﬁcients for direct and indirect (mediated) paths for
patients in the pregabalin group indicated less sleep disturbance
with treatment. Fifty-three percent of the reduction in sleep dis-
turbance was due to the direct effect of pregabalin (p = 0.007).
The remainder of the reduction in sleep disturbance (47%, p =
0.015) was mediated via anxiety symptoms. In contrast, there
was no difference in sleep disturbance (p = 0.58) between patients
treated with venlafaxine XR or placebo. CONCLUSIONS: The
underlying relationships between treatment, anxiety symptoms,
and sleep disturbance are explicitly described and partitioned
through mediation modeling. About half of the total improve-
ment in sleep disturbance was identiﬁed as being due to the
direct effect of pregabalin independent of an effect on anxiety
symptoms.
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OBJECTIVES: To evaluate preliminary treatment outcomes of
Russian patients enrolled in the electronic-Schizophrenia Treat-
ment Adherence Registry (e-STAR) followed up for three months
after initiating treatment with risperidone long-acting injectable
(RLAI). METHODS: e-STAR is an international, prospective,
observational study of schizophrenia patients initiated on RLAI.
Psychiatric hospitalisations and medication use are collected ret-
rospectively for one year and prospectively every three months
for two years. Clinical and functioning outcomes, which are
measured by the Clinical Global Impression Severity (CGI-S)
Scale and the Global Assessment of Functioning (GAF) Scale,
respectively, are assessed prospectively every three months for
two years. McNemar’s test and paired-t test were used to evalu-
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